Olema Pharmaceuticals, Inc. (OLMA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$10.75+0.19%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · OLMA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 190.2 | 157.7 | 124.5 | 86.1 | 82.3 | 51.1 | 13.7 |
| Operating Income | (221.1) | (178.7) | (142.3) | (105.0) | (107.0) | (71.5) | (21.5) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | — | — | — | 0.7 |
| Interest & Investment Income | 16.9 | 16.2 | 12.7 | 8.3 | 2.2 | 0.4 | 0.1 |
| Net Interest Expenses | — | — | — | — | — | — | 0.6 |
| Other Non-Operating Income / Expenses | 16.6 | 16.2 | 12.8 | 8.3 | 2.2 | 0.4 | (0.6) |
| EBT, Incl. Unusual Items | — | (162.4) | — | — | — | — | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | |||||||
| Net Income | (204.6) | (162.5) | (129.5) | (96.7) | (104.8) | (71.1) | (22.1) |
| Per Share | |||||||
| Basic EPS | (1.96) | (1.87) | (2.20) | (2.14) | (2.62) | (1.80) | (3.42) |
| Diluted EPS | (1.96) | (1.87) | (2.20) | (2.14) | (2.62) | (1.80) | (3.42) |
| Basic Weighted Avg Shares | 104.5 | 87.0 | 58.7 | 45.2 | 40.0 | 39.5 | 7.0 |
| Diluted Weighted Avg Shares | 104.5 | 87.0 | 58.7 | 45.2 | 40.0 | 39.5 | 7.0 |
| Supplemental | |||||||
| EBITDA | — | (178.2) | (141.9) | (104.6) | (106.6) | (71.3) | (21.5) |
| EBIT | (221.1) | (178.7) | (142.3) | (105.0) | (107.0) | (71.5) | (21.5) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.